Biological E and Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses Read more
We plan to continue expanding our footprints in India, including producing quality excipients and introducing new products Read more
Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry Read more
We will maintain a growth rate in the high teens for both (CDMO and API business) in the next few years Read more